DERM
Income statement / Annual
Last year (2023), Journey Medical Corporation's total revenue was $79.18 M,
an increase of 7.48% from the previous year.
In 2023, Journey Medical Corporation's net income was -$3.85 M.
See Journey Medical Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$79.18 M
|
$73.67 M
|
$63.13 M
|
$44.53 M
|
$34.92 M
|
$42.34 M
|
$4.54 M
|
$22.59 M
|
$7.30 M
|
$7.30 M
|
| Cost of Revenue |
$26.66 M |
$30.78 M |
$32.08 M |
$14.59 M |
$10.53 M |
$1.18 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$52.52 M |
$42.89 M |
$31.05 M |
$29.94 M |
$24.39 M |
$41.16 M |
$4.54 M |
$22.59 M |
$7.30 M |
$7.30 M |
| Gross Profit Ratio |
0.66 |
0.58 |
0.49 |
0.67 |
0.7 |
0.97 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$7.54 M
|
$10.94 M
|
$16.56 M
|
$0.00
|
$0.00
|
$80.55 M
|
$104.41 M
|
$83.17 M
|
$66.83 M
|
$30.71 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$172.58 M
|
$71.90 M
|
$30.04 M
|
$17.72 M
|
$8.29 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$43.91 M
|
$59.47 M
|
$39.83 M
|
$22.09 M
|
$19.13 M
|
$172.58 M
|
$71.90 M
|
$30.04 M
|
$17.72 M
|
$8.29 M
|
| Other Expenses |
$3.14 M |
$0.00 |
$23.36 M |
$0.00 |
$0.00 |
$2.02 M |
$128.56 M |
$0.00 |
$2.52 M |
$0.00 |
| Operating Expenses |
$54.59 M |
$70.41 M |
$56.39 M |
$22.09 M |
$19.13 M |
$255.15 M |
$304.87 M |
$113.21 M |
$87.07 M |
$39.00 M |
| Cost And Expenses |
$81.25 M |
$101.19 M |
$88.48 M |
$36.68 M |
$29.66 M |
$256.32 M |
$304.87 M |
$113.21 M |
$87.07 M |
$39.00 M |
| Interest Income |
$322,000.00 |
$60,000.00 |
$2,000.00 |
$698,000.00 |
$255,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.70 M |
$2.02 M |
$7.03 M |
$698,000.00 |
$255,000.00 |
$15.64 M |
$8.14 M |
$1.54 M |
$147,000.00 |
$153,000.00 |
| Depreciation &
Amortization |
$3.86 M
|
$4.37 M
|
$2.56 M
|
$1.52 M
|
$1.21 M
|
$555,000.00
|
$339,000.00
|
$123,000.00
|
$72,000.00
|
$47,000.00
|
| EBITDA |
$1.92 M
|
-$23.18 M
|
-$32.77 M
|
$9.37 M
|
$6.44 M
|
-$205.54 M
|
-$294.78 M
|
-$87.42 M
|
-$78.80 M
|
-$31.64 M
|
| EBITDA Ratio |
0.02 |
-0.37 |
-0.4 |
0.21 |
0.19 |
-4.85 |
-64.92 |
-3.87 |
-10.79 |
-4.33 |
| Operating Income Ratio
|
-0.03
|
-0.37
|
-0.4
|
0.18
|
0.15
|
-5.05
|
-66.14
|
-4.01
|
-10.93
|
-4.34
|
| Total Other
Income/Expenses Net |
-$1.56 M
|
-$2.05 M
|
-$7.48 M
|
-$698,000.00
|
-$255,000.00
|
-$7.75 M
|
-$2.94 M
|
$1.54 M
|
$749,000.00
|
-$146,000.00
|
| Income Before Tax |
-$3.63 M |
-$29.57 M |
-$42.36 M |
$7.15 M |
$5.00 M |
-$221.73 M |
-$303.26 M |
-$89.08 M |
-$79.02 M |
-$31.84 M |
| Income Before Tax Ratio
|
-0.05
|
-0.4
|
-0.67
|
0.16
|
0.14
|
-5.24
|
-66.78
|
-3.94
|
-10.82
|
-4.36
|
| Income Tax Expense |
$221,000.00 |
$63,000.00 |
$1.63 M |
$1.87 M |
$1.38 M |
-$194,000.00 |
$5.21 M |
$3.08 M |
-$622,000.00 |
$31,000.00 |
| Net Income |
-$3.85 M |
-$29.63 M |
-$43.99 M |
$5.28 M |
$3.63 M |
-$221.54 M |
-$303.26 M |
-$89.08 M |
-$78.40 M |
-$31.88 M |
| Net Income Ratio |
-0.05 |
-0.4 |
-0.7 |
0.12 |
0.1 |
-5.23 |
-66.78 |
-3.94 |
-10.74 |
-4.37 |
| EPS |
-0.21 |
-1.69 |
-2.54 |
0.32 |
0.22 |
-5.27 |
-7.48 |
-2.7 |
-2.93 |
-4.96 |
| EPS Diluted |
-0.21 |
-1.69 |
-2.54 |
0.32 |
0.22 |
-5.27 |
-7.48 |
-2.7 |
-2.93 |
-4.96 |
| Weighted Average Shares
Out |
$18.23 M
|
$17.53 M
|
$17.32 M
|
$16.66 M
|
$16.66 M
|
$42.00 M
|
$40.56 M
|
$33.04 M
|
$26.73 M
|
$6.43 M
|
| Weighted Average Shares
Out Diluted |
$18.23 M
|
$17.53 M
|
$17.32 M
|
$16.66 M
|
$16.66 M
|
$42.00 M
|
$40.56 M
|
$33.04 M
|
$26.73 M
|
$6.43 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
